Followers | 37 |
Posts | 4190 |
Boards Moderated | 0 |
Alias Born | 10/18/2016 |
Tuesday, January 16, 2018 9:40:29 AM
Blockchain-focused venture builder Victory Square Technologies Inc. (CSE: VST) (OTC: VSQTF) (FRANKFURT: 6F6) (WKN: A2AKL8) this morning announced that it has become an early strategic adopter, investor and partner in the Gibraltar Blockchain Exchange (“GBX”). Based in Gibraltar, the GBX is a subsidiary of the Gibraltar Stock Exchange (“GSX”), a European Union-regulated stock exchange since 2014. Victory Square’s investment of $150,000 connects the company with the GBX partnership network and well-known blockchain services firms such as Enterprise Ethereum Alliance, PricewaterhouseCoopers, ISOLAS and Kenetic Capital. Additionally, Victory Square will receive 1.5 million cryptographic tokens, known as Rock Tokens, issued by the crowd-contribution smart-contract. “The Gibraltar Blockchain Exchange represents a tremendous opportunity to partner with the world’s first licensed and regulated token sale platform and digital asset exchange that is operated by an EU-regulated stock exchange,” Shafin Diamond Tejani, CEO of Victory Square, stated in the news release. “The GBX is expected to be a global listing and token sales springboard for utility tokens that have satisfied a strict due diligence and admissions process as well as a high-quality digital asset exchange.”
To view the full press release, visit http://nnw.fm/D36nI
About Victory Square Technologies Inc.
Victory Square Technologies is a blockchain-focused venture builder that funds and empowers entrepreneurs to implement innovative blockchain solutions. Victory Square portfolio companies are disrupting every sector of the global economy including Virtual Reality, Artificial Intelligence, Personalized Health, Gaming and Film. Victory Square has a proven process for identifying game-changing entrepreneurs and providing them with the partners, mentorship and support necessary to accelerate their growth and help them scale globally. For more information, please visit www.VictorySquare.com
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM